Skip to the reading
Under the Tongue

Where do Sublingual Peptides go from here?

Under the tongue, then where?

Under the tongue tells you where something starts, but leaves open how much reaches the blood.

Daylight caught in rain on bright green bus shelter glass, with the street softly blurred beyond

A place is only the start

Sublingual is a grand word for a small place: under the tongue. Once that's translated, the interesting question is what happens next. Does the substance reach the blood, and does it help anyone?

A peptide is a short chain of the building blocks in proteins. The name tells us something about its chemistry. It doesn't tell us whether a particular medicine works.

I think of a parcel. Knowing what's inside isn't the same as knowing it arrived. The route comparison follows that missing part of the journey, keeping swallowed, under-the-tongue and injected preparations separate.

One swallowed medicine has its own story

Semaglutide has approved swallowed tablets. That's a useful example of a peptide medicine with evidence for a particular product and route.

It isn't a shortcut for every other peptide. A tablet that goes to the stomach doesn't answer a question about something placed under the tongue. Sharing an ingredient name doesn't make two preparations equivalent, either.

The semaglutide page explains why. BPC-157 and CJC-1295 have different research stories, with different gaps. One success doesn't fill them all.

Three questions for a care conversation

What exactly is it? The full ingredient name and preparation give the conversation a clear starting point.

Was this route studied in people? A rat experiment or an injection study may be interesting without answering that question.

What did the study measure? Finding a substance in blood, changing a hormone level and helping someone feel better are different results.

A prescription is an individual care decision. It doesn't fill a research gap. For compounded medicines, FDA hasn't checked safety, effectiveness or quality before marketing. They aren't FDA-approved.

Then where?

I like how those two words slow the claim down. It turns a big promise into something we can actually examine: this preparation, by this route, with this result.

The sources used here don't establish human sublingual absorption for BPC-157 or CJC-1295. That leaves an unanswered question, rather than proof that nothing gets through.

The BPC 157 sublingual questions are a good next stop. The sources are there whenever you want to look past the explanation and see what the research actually covered.